Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Stat3em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Stat3em1flox/Cya

Common Name
Stat3-flox
Product ID
S-CKO-05338
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-20848-Stat3-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Stat3-flox Mouse (Catalog S-CKO-05338) were purchased from Cyagen.”
cKO Models
JAK-STAT signaling pathway
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
JAK-STAT signaling pathway
Basic Information
Strain Name
Stat3-flox
Strain ID
CKOCMP-20848-Stat3-B6J-VA
Gene Name
Stat3
Product ID
S-CKO-05338
Gene Alias
Aprf, 1110034C02Rik
Background
C57BL/6JCya
Gene Full Name
signal transducer and activator of transcription 3
Modification
Conditional knockout
NCBI ID
20848 (Mouse)
Phenotype
MGI:103038
Chromosome
Chr 11 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000127638
NCBI Transcript ID
NM_213659
Target Region
Exon 3~4
Size of Effective Region
~1.4 kb
Overview of Gene Research
Stat3, short for signal transducer and activator of transcription 3, is a nuclear transcription factor. It is a key member of the JAK/STAT signaling pathway. STAT3 regulates genes involved in cell cycle, cell survival, and immune response [4]. It has a crucial role in numerous biological processes and is associated with various diseases [1-3, 5-7].

STAT3 is broadly hyperactivated in the tumor ecosystem, both in cancer and non-cancerous cells. It inhibits the expression of immune activation regulators and promotes immunosuppressive factor production, making targeting its signaling pathway a promising cancer therapeutic strategy [1]. In liver fibrosis, its activation can have anti-or pro-inflammatory roles [2]. In breast cancer, overexpressed and constitutively activated STAT3 is involved in progression, proliferation, metastasis, and chemoresistance [3]. In pancreatic cancer, STAT3 binds to the GPX4 promoter region to promote its transcription, and thiostrepton can block GPX4 expression by regulating STAT3, inducing ferroptosis [5]. In breast cancer, PRMT6-mediated methylation of STAT3 at arginine 729 is important for its membrane localization, phosphorylation, and cancer cell metastasis [6]. In kidney disease, dysregulated STAT3 activation is detrimental, and inhibiting its activity has salutary benefits in some kidney disease models [7].

In conclusion, Stat3 is essential in regulating cell-related functions and immune responses. Through studies including gene knockout or conditional knockout mouse models (implied by genetic knockout and manipulation studies in kidney disease [7]), its role in cancer, liver fibrosis, and kidney disease has been revealed. Understanding Stat3's functions contributes to developing new therapeutic strategies for these diseases.

References:
1. Zou, Sailan, Tong, Qiyu, Liu, Bowen, Tian, Yan, Fu, Xianghui. 2020. Targeting STAT3 in Cancer Immunotherapy. In Molecular cancer, 19, 145. doi:10.1186/s12943-020-01258-7. https://pubmed.ncbi.nlm.nih.gov/32972405/
2. Zhao, Jie, Qi, Yong-Fen, Yu, Yan-Rong. 2020. STAT3: A key regulator in liver fibrosis. In Annals of hepatology, 21, 100224. doi:10.1016/j.aohep.2020.06.010. https://pubmed.ncbi.nlm.nih.gov/32702499/
3. Ma, Jia-Hui, Qin, Li, Li, Xia. 2020. Role of STAT3 signaling pathway in breast cancer. In Cell communication and signaling : CCS, 18, 33. doi:10.1186/s12964-020-0527-z. https://pubmed.ncbi.nlm.nih.gov/32111215/
4. Butturini, Elena, Carcereri de Prati, Alessandra, Mariotto, Sofia. 2020. Redox Regulation of STAT1 and STAT3 Signaling. In International journal of molecular sciences, 21, . doi:10.3390/ijms21197034. https://pubmed.ncbi.nlm.nih.gov/32987855/
5. Zhang, Weifan, Gong, Mengyuan, Zhang, Wunai, Ma, Qingyong, Wang, Zheng. 2022. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3/GPX4 signalling. In Cell death & disease, 13, 630. doi:10.1038/s41419-022-05082-3. https://pubmed.ncbi.nlm.nih.gov/35859150/
6. Chen, Qianzhi, Hu, Qingyi, Chen, Yan, Li, Lei, Li, Junjun. 2023. PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer. In Cell death & disease, 14, 655. doi:10.1038/s41419-023-06148-6. https://pubmed.ncbi.nlm.nih.gov/37813837/
7. Pace, Jesse, Paladugu, Praharshasai, Das, Bhaskar, He, John C, Mallipattu, Sandeep K. 2019. Targeting STAT3 signaling in kidney disease. In American journal of physiology. Renal physiology, 316, F1151-F1161. doi:10.1152/ajprenal.00034.2019. https://pubmed.ncbi.nlm.nih.gov/30943069/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Publications
Journal of the American Heart Association
2022-11-11
SENP1 Protects Against Pressure Overload-Induced Cardiac Remodeling and Dysfunction Via Inhibiting STAT3 Signaling
Read More
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research